Cepheid has introduced the GeneXpert ® 16-Site System at the 106th Annual Meeting of the American Society for Microbiology. The latest addition to Cepheid's GeneXpert ® family of real-time PCR devices ...
Renowned molecular diagnostics provider CepheidCPHD recently entered into a non-exclusive distribution agreement with Henry Schein Medical, the Medical business of one of the leading healthcare ...
Background: The identification of non-tuberculosis (TB) mycobacterial (NTM) infection remains a significant challenge. This study aims to investigate the diagnostic value of multicolour nested ...
Tuberculosis has high prevalence in India. 26% of the cases of tuberculosis are here in India. There are many people that are affected but most importantly 850,000 people go undetected, or undiagnosed ...
The Xpert MTB/XDR test developed by the Foundation for Innovative New Diagnostics (FIND) and Cepheid Inc. quickly indicates whether a patient has a dangerous – and rapidly increasing – strain of ...
On November 4, 2022, the United States, through the United States Agency for International Development (USAID), donated 126 cutting-edge GeneXpert tuberculosis (TB) testing machines worth U.S. $3 ...
The World Health Organisation (WHO) continues to emphasise the critically important role testing plays in curbing the rampaging spread of the pandemic coronavirus (COVID-19). It describes testing as a ...
The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. Nunavut's Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results